Opportunity Information: Apply for RFA NS 13 002
Apply for RFA NS 13 002
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Limited Competition for Continuation of the NIH Exploratory Trials in Parkinsons Disease (NET PD) Clinical Sites (U10)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders.
- This funding opportunity was created on Jan 31, 2012 and posted on Jan 31, 2012.
- Applicants must submit their applications by Apr 17, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $3,750,000.00 to eligible and selected applicants.
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Other Eligible Applicants include the following Only currently active NET PD Clinical Sites are eligible to apply. Non domestic (non U.S.) Entities (Foreign Institutions) are eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity (RFA-NS-13-002) is a limited-competition NIH grant from the National Institute of Neurological Disorders and Stroke (NINDS) aimed at continuing support for already-established clinical sites participating in the NIH Exploratory Trials in Parkinsons Disease network (NET PD). The mechanism is a Cooperative Agreement (U10), which signals that NINDS expects substantial scientific and programmatic involvement during the award period. In practical terms, the FOA is designed to keep the existing NET PD clinical infrastructure operating so the network can finish the Parkinsons disease clinical trials that are already underway, rather than launching a broad new round of site expansion or unrelated studies.
The central purpose of the award is continuity: maintaining the capacity of NET PD clinical sites to recruit and follow participants, implement study protocols consistently across locations, collect high-quality trial data, and meet the operational demands that come with multicenter clinical research. The description emphasizes completing NET PDs current ongoing clinical trials, so applicants are essentially being supported to continue executing active studies to their planned endpoints. Because the announcement is framed as continuation support within a standing network, the focus is on ensuring that trial operations remain stable, compliant, and coordinated across sites so that the ongoing trials can be concluded successfully.
Eligibility is intentionally narrow. Only currently active NET PD Clinical Sites are eligible to apply, which is why it is described as a limited competition. This excludes new institutions that are not already part of the active NET PD clinical site roster. At the same time, the FOA explicitly allows non-U.S. entities to apply, along with non-U.S. components of U.S. organizations and other foreign components as defined in the NIH Grants Policy Statement. That language indicates that NET PD may include international sites or collaborators and that NINDS is willing to continue supporting those eligible, already-active sites under the same continuation framework.
Administratively, the opportunity is categorized as discretionary funding and falls under the health activity area, tied to CFDA 93.853 (Extramural Research Programs in the Neurosciences and Neurological Disorders). The FOA states there is no cost sharing or matching requirement, meaning applicants are not required to contribute institutional matching funds as a condition of the award. The estimated total funding level listed is $3,750,000, representing the approximate amount NIH expected to commit under this announcement, subject to appropriations and program priorities.
Key dates reflect that this was a time-limited announcement. It was posted and created on January 31, 2012, with an original and current closing date of April 17, 2012, and an archive date of May 18, 2012. Those dates show it was a single-cycle, targeted continuation FOA rather than an ongoing, open-submission program. The official announcement and full details were hosted on the NIH Grants Guide page referenced in the Additional Information link.
Overall, this FOA is best understood as a bridge-and-completion support mechanism for the NET PD network: it keeps existing, active clinical sites funded under a cooperative agreement structure so they can continue enrolling and monitoring participants, adhering to standardized protocols, and delivering the operational performance needed to complete the networks current Parkinsons disease clinical trials. For technical access issues, the listed point of contact is the NIH Office of Extramural Research (OER) Webmaster email, which is typical for archived or electronically hosted NIH FOAs.
Frequently Asked Questions (FAQs)
What is the funding opportunity number for this grant?
The funding opportunity is RFA-NS-13-002.
Which agency and institute are offering this opportunity?
This is an NIH funding opportunity offered by the National Institute of Neurological Disorders and Stroke (NINDS).
What network does this opportunity support?
It supports the NIH Exploratory Trials in Parkinsons Disease network (NET PD), specifically its already-established clinical sites.
What is the main purpose of this FOA?
The central purpose is continuity of operations for existing NET PD Clinical Sites so the network can complete Parkinsons disease clinical trials that are already underway. The emphasis is on keeping the current clinical infrastructure functioning rather than expanding the network or starting unrelated studies.
Is this funding meant to start new clinical trials or expand to new sites?
No. The description emphasizes maintaining the existing NET PD infrastructure to finish ongoing Parkinsons disease clinical trials, not launching a broad new round of site expansion or unrelated studies.
What grant mechanism is used for this opportunity?
The mechanism is a Cooperative Agreement (U10).
What does the Cooperative Agreement (U10) structure imply?
It indicates that NINDS expects substantial scientific and programmatic involvement during the award period, consistent with the cooperative agreement structure.
Who is eligible to apply?
Eligibility is limited to currently active NET PD Clinical Sites. This is why the FOA is described as a limited competition.
Are new institutions that are not part of NET PD eligible to apply?
No. New institutions that are not already part of the active NET PD clinical site roster are excluded by the eligibility limitation.
Are non-U.S. organizations eligible to apply?
Yes. The FOA explicitly allows non-U.S. entities to apply, as well as non-U.S. components of U.S. organizations and other foreign components as defined in the NIH Grants Policy Statement, provided they are currently active NET PD Clinical Sites.
What activities or capabilities is the FOA trying to maintain at clinical sites?
The FOA is designed to maintain the capacity of NET PD clinical sites to recruit and follow participants, implement study protocols consistently across locations, collect high-quality trial data, and meet the operational demands of multicenter clinical research so ongoing trials can be completed successfully.
What is the estimated total funding level for this announcement?
The estimated total funding level is $3,750,000 (approximately), subject to appropriations and program priorities.
Is cost sharing or matching required?
No. The FOA states there is no cost sharing or matching requirement.
How is this opportunity categorized (funding type and activity area)?
It is categorized as discretionary funding and falls under the health activity area.
What CFDA number is associated with this opportunity?
The CFDA number is 93.853 (Extramural Research Programs in the Neurosciences and Neurological Disorders).
When was the FOA posted/created?
It was posted and created on January 31, 2012.
What was the application closing date?
The original and current closing date listed is April 17, 2012.
When was the FOA archived?
The archive date is May 18, 2012.
Does this appear to be an ongoing/open-submission program?
No. The dates indicate it was a time-limited, single-cycle, targeted continuation FOA rather than an ongoing open-submission program.
Where were the official announcement and full details hosted?
The official announcement and full details were hosted on the NIH Grants Guide page referenced in the Additional Information link.
What is this FOA best understood as, in practical terms?
It is a bridge-and-completion support mechanism to keep existing NET PD clinical sites operating under a cooperative agreement structure so they can continue enrolling and monitoring participants, adhere to standardized protocols, and deliver the operational performance needed to complete current Parkinsons disease clinical trials.
Who is listed as the point of contact for technical access issues?
The listed point of contact for technical access issues is the NIH Office of Extramural Research (OER) Webmaster email.
Browse more opportunities from the same category: Health
Next opportunity: Resource support for Consortiums for HIV/AIDS and Alcohol Related Outcomes Research Trials (CHAART) U24
Previous opportunity: Limited Competition for Continuation of the NIH Exploratory Trials in Parkinsons Disease (NET PD) Coordinating and Statistical Centers (U01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA NS 13 002
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA NS 13 002) also looked into and applied for these:
| Funding Opportunity |
|---|
| Resource support for Consortiums for HIV/AIDS and Alcohol Related Outcomes Research Trials (CHAART) U24 Apply for RFA AA 12 010 Funding Number: RFA AA 12 010 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Strengthening Federal Coordination and Monitoring and Evaluation of the Multi Sectoral response to HIV/AIDS in Ethiopia under the Presidents Emergency Plan for AIDS Relief (PEPFAR). Apply for CDC RFA GH12 1220 Funding Number: CDC RFA GH12 1220 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,050,000 |
| HIV Vaccine Research and Design (HIVRAD) Program (P01) Apply for PAR 12 087 Funding Number: PAR 12 087 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Strengthening of the National External Quality Assessment (EQA) Program through Establishment and Implementation of an Efficient Distribution and Analysis of Proficiency Materials for Human Immunodeficiency Virus (HIV), Tuberculosis, and Opportunisti Apply for CDC RFA GH12 1234 Funding Number: CDC RFA GH12 1234 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $250,000 |
| Partnerships for Development of Vaccine Technologies (R01) Apply for RFA AI 12 014 Funding Number: RFA AI 12 014 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Resource Access for the Bridging Interventional Development Gaps Program (X01) Apply for PAR 12 092 Funding Number: PAR 12 092 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NU HITES Apply for RFA 617 12 000005 Funding Number: RFA 617 12 000005 Agency: Uganda USAID Kampala Category: Health Funding Amount: $50,000,000 |
| Strengthening Systems, Capacity, and Data Collection with a Focus on Strategic Information in South Sudan under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1256 Funding Number: CDC RFA GH12 1256 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,000,000 |
| Engaging Local Indigenous Organizations in Improving Quality and Efficiency of HIV Care and Treatment Services in Ukraine under the Presidents Emergency Plan for HIV/AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1227 Funding Number: CDC RFA GH12 1227 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $700,000 |
| Establishment of an expanded Caribbean HIV/AIDS monitoring and evaluation technical assistance unit within the Caribbean Health Research Council (CHRC) under the Presidents Emergency Plan for AIDS Relief (PEPFAR Apply for CDC RFA GH12 1205 Funding Number: CDC RFA GH12 1205 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| Planning Grant The Money Follows the Person Rebalancing Demonstration Program Apply for CMS 1LI 12 001 Funding Number: CMS 1LI 12 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $200,000 |
| Expanding Participation of People with Disabilities in USAID Activities andStrengthen the Capacities of Disabled Peoples Organizations (DPOs) Apply for RFA 114 12 000002 Funding Number: RFA 114 12 000002 Agency: Georgia USAID Tbilisi Category: Health Funding Amount: $600,000 |
| Implementation of a Program to Build the Institutional Apply for CDC RFA GH12 1243 Funding Number: CDC RFA GH12 1243 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,130,000 |
| Modeling Social Behavior (R01) Apply for RFA GM 13 006 Funding Number: RFA GM 13 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Grand Challenges in Global Mental Health Integrating Mental Health into Chronic Disease Care Provision in Low and Middle Income Countries (R01) Apply for RFA MH 13 040 Funding Number: RFA MH 13 040 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Increasing Human Resources for Health and Epidemiological Capacity in the Republic of Guyana through a University Training Program under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1208 Funding Number: CDC RFA GH12 1208 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $440,000 |
| Sober Truth on Preventing Underage Drinking Act Grants Apply for SP 12 003 Funding Number: SP 12 003 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $50,000 |
| Improving Quality of Care and Health Impact through Sustainable, Integrated, Innovative Information System Technologies in Malawi under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1250 Funding Number: CDC RFA GH12 1250 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $8,000,000 |
| Ancillary Studies in PREDICT HD (U01) Apply for PAR 12 097 Funding Number: PAR 12 097 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Ancillary Domain Validation Patient Reported Outcomes Measurement Information System (PROMIS) Studies (R01) Apply for RFA AR 12 007 Funding Number: RFA AR 12 007 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA NS 13 002", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.